Skip to Content


SENATE DOCKET, NO. 1020         FILED ON: 1/17/2013

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 303

 

The Commonwealth of Massachusetts

_________________

PRESENTED BY:

Kathleen O'Connor Ives

_______________

To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
              Court assembled:

              The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:

An Act relative to psychotropic medications.

_______________

PETITION OF:

 

Name:

District/Address:

Kathleen O'Connor Ives

First Essex

Marc R. Pacheco

First Plymouth and Bristol

Patricia D. Jehlen

Second Middlesex

Bruce E. Tarr

First Essex and Middlesex


SENATE DOCKET, NO. 1020        FILED ON: 1/17/2013

SENATE  .  .  .  .  .  .  .  .  .  .  .  .  .  .  No. 303

By Ms. O'Connor Ives, a petition (accompanied by bill, Senate, No. 303) of Kathleen O'Connor Ives, Marc R. Pacheco, Patricia D. Jehlen and Bruce E. Tarr for legislation relative to psychotropic medications.  Elder Affairs. 


The Commonwealth of Massachusetts
 

_______________

In the Year Two Thousand Thirteen

_______________

 

An Act relative to psychotropic medications.
 

              Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
 

              Chapter 111 of the General Laws, as appearing in the 2010 Official  Edition, is hereby amended by inserting after section 72AA the following section:—

              Section 72BB.  Prior to administering a psychotropic medication to a resident, a nursing home, rest home, or other long term care facility shall obtain informed written consent from the resident, the resident’s health care proxy, or a court appointed Rogers guardian. The written consent form shall state the purpose, use and any effects or side effects of the psychotropic medication. Such written consent form shall be kept in the resident’s medical record. As used in this section, “psychotropic medication” shall mean a chemical substance that acts primarily upon the central nervous system where it alters brain function, resulting in temporary changes in perception, mood,  consciousness and behavior.

The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

Error